Skip to content

Aurinia Pharmaceuticals AUPH Accounts Receivable

Accounts Receivable at other companies

Rogers Corporation logo
Rogers CorporationROG
$142.1M+2.1%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$255.43M+15.9%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$121M+22.4%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$16.13M+382%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$23.22M-42.0%
LQD
Liquidia CorporationLQDA
$74.16M+5,847%

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.39B+78.5%

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccountsAndOtherReceivablesNetCurrent.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's accounts receivable?
Aurinia Pharmaceuticals (AUPH) reported accounts receivable of $49.18M in Q1 2026.
How has Aurinia Pharmaceuticals's accounts receivable changed year-over-year?
Aurinia Pharmaceuticals's accounts receivable increased by 21.9% year-over-year, from $40.35M to $49.18M.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.